Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092152092> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2092152092 abstract "Objective: The objective of this single-center, open-label trial was to evaluate the percutaneous penetration of Aldara (imiquimod) cream, 5% when applied topically to patients with anogenital warts using a more frequent/aggressive dosing regimen.Methods: Ten otherwise healthy males and six otherwise healthy, nonpregnant, nonlactating females with histology results suggestive of, or diagnostic of, human papilloma virus/condyloma acuminata were enrolled. Females were required to be practicing an acceptable form of contraception control. Patients applied cream daily (8 +/- 2 hours) until complete wart clearance, or for a maximum of 16 weeks. Following the initial dose, at approximately week 4, and at the end-of-treatment, patients were confined for 42 hours in order to obtain a series of blood and urine samples. These samples were analyzed for levels of imiquimod and two metabolites, S-26704 and S-27700. Biological marker levels were not included as a part of this trial.Results: No quantifiable (>/=5 ng/mL) levels of imiquimod or the two metabolites were observed in any of the serum samples collected. Five patients had quantifiable (>/=10 ng/mL) imiquimod, S-26704, or both in urine. No quantifiable levels of S-27700 were observed. Complete clearance of warts occurred in 40% of male patients and 83% of female patients. Erythema was the most frequently observed local skin reaction and was moderate in intensity, although 6 of 16 patients reported a severe erythema reaction at some point in the study. Application site reactions (itching, burning and pain) were the most frequently reported adverse events.Conclusion: The lack of quantifiable levels of imiquimod or metabolites in serum, together with sporadically occurring quantifiable but low levels in urine, indicate that systemic exposure, after daily application of Aldara cream to genital/perianal skin, may occur but is minimal; however, pharmacological (immune marker) effects were not evaluated because cytokine measurements were not obtained. A future trial assessing cytokine levels after topical Aldara therapy with minimal systemic levels of imiquimod would help assess systemic drug and pharmacological effects and utility of this product in pregnant women." @default.
- W2092152092 created "2016-06-24" @default.
- W2092152092 creator A5015513412 @default.
- W2092152092 creator A5043879269 @default.
- W2092152092 creator A5048155249 @default.
- W2092152092 creator A5062063792 @default.
- W2092152092 creator A5077682980 @default.
- W2092152092 creator A5087226454 @default.
- W2092152092 date "1998-07-01" @default.
- W2092152092 modified "2023-10-01" @default.
- W2092152092 title "Percutaneous penetration of Aldara™ cream, 5% during the topical treatment of genital and perianal warts" @default.
- W2092152092 doi "https://doi.org/10.1016/s1068-607x(98)00034-1" @default.
- W2092152092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10838279" @default.
- W2092152092 hasPublicationYear "1998" @default.
- W2092152092 type Work @default.
- W2092152092 sameAs 2092152092 @default.
- W2092152092 citedByCount "21" @default.
- W2092152092 countsByYear W20921520922012 @default.
- W2092152092 countsByYear W20921520922015 @default.
- W2092152092 countsByYear W20921520922016 @default.
- W2092152092 countsByYear W20921520922018 @default.
- W2092152092 countsByYear W20921520922023 @default.
- W2092152092 crossrefType "journal-article" @default.
- W2092152092 hasAuthorship W2092152092A5015513412 @default.
- W2092152092 hasAuthorship W2092152092A5043879269 @default.
- W2092152092 hasAuthorship W2092152092A5048155249 @default.
- W2092152092 hasAuthorship W2092152092A5062063792 @default.
- W2092152092 hasAuthorship W2092152092A5077682980 @default.
- W2092152092 hasAuthorship W2092152092A5087226454 @default.
- W2092152092 hasConcept C121608353 @default.
- W2092152092 hasConcept C126322002 @default.
- W2092152092 hasConcept C16005928 @default.
- W2092152092 hasConcept C183021626 @default.
- W2092152092 hasConcept C197934379 @default.
- W2092152092 hasConcept C2777288759 @default.
- W2092152092 hasConcept C2778220009 @default.
- W2092152092 hasConcept C2778308922 @default.
- W2092152092 hasConcept C2779112978 @default.
- W2092152092 hasConcept C2779121184 @default.
- W2092152092 hasConcept C2779923671 @default.
- W2092152092 hasConcept C2780026642 @default.
- W2092152092 hasConcept C54355233 @default.
- W2092152092 hasConcept C71924100 @default.
- W2092152092 hasConcept C86803240 @default.
- W2092152092 hasConceptScore W2092152092C121608353 @default.
- W2092152092 hasConceptScore W2092152092C126322002 @default.
- W2092152092 hasConceptScore W2092152092C16005928 @default.
- W2092152092 hasConceptScore W2092152092C183021626 @default.
- W2092152092 hasConceptScore W2092152092C197934379 @default.
- W2092152092 hasConceptScore W2092152092C2777288759 @default.
- W2092152092 hasConceptScore W2092152092C2778220009 @default.
- W2092152092 hasConceptScore W2092152092C2778308922 @default.
- W2092152092 hasConceptScore W2092152092C2779112978 @default.
- W2092152092 hasConceptScore W2092152092C2779121184 @default.
- W2092152092 hasConceptScore W2092152092C2779923671 @default.
- W2092152092 hasConceptScore W2092152092C2780026642 @default.
- W2092152092 hasConceptScore W2092152092C54355233 @default.
- W2092152092 hasConceptScore W2092152092C71924100 @default.
- W2092152092 hasConceptScore W2092152092C86803240 @default.
- W2092152092 hasLocation W20921520921 @default.
- W2092152092 hasLocation W20921520922 @default.
- W2092152092 hasOpenAccess W2092152092 @default.
- W2092152092 hasPrimaryLocation W20921520921 @default.
- W2092152092 hasRelatedWork W1972776583 @default.
- W2092152092 hasRelatedWork W1991359478 @default.
- W2092152092 hasRelatedWork W1996136370 @default.
- W2092152092 hasRelatedWork W2004751790 @default.
- W2092152092 hasRelatedWork W2044066549 @default.
- W2092152092 hasRelatedWork W2045774787 @default.
- W2092152092 hasRelatedWork W2050769690 @default.
- W2092152092 hasRelatedWork W2064019766 @default.
- W2092152092 hasRelatedWork W2095995872 @default.
- W2092152092 hasRelatedWork W2130452292 @default.
- W2092152092 hasRelatedWork W2169142074 @default.
- W2092152092 hasRelatedWork W2356100997 @default.
- W2092152092 hasRelatedWork W2401376571 @default.
- W2092152092 hasRelatedWork W2418979545 @default.
- W2092152092 hasRelatedWork W250867744 @default.
- W2092152092 hasRelatedWork W3011026987 @default.
- W2092152092 hasRelatedWork W3121842246 @default.
- W2092152092 hasRelatedWork W3149919770 @default.
- W2092152092 hasRelatedWork W2205903184 @default.
- W2092152092 hasRelatedWork W3022240365 @default.
- W2092152092 isParatext "false" @default.
- W2092152092 isRetracted "false" @default.
- W2092152092 magId "2092152092" @default.
- W2092152092 workType "article" @default.